Physician profile
Peter T White
NPI 1619264165
$14,638.97
in general payments reported to CMS, 2019-2025
12 companies · $6,958 in 2025
The $6,958 reported for 2025 was more than what 86% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,298 · 2020: $1,521 · 2021: $788 · 2022: $358 · 2023: $2,015 · 2024: $1,702 · 2025: $6,958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Food and Beverage: $2,656 · Travel and Lodging: $2,519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Food and Beverage | $2,655.73 |
| Travel and Lodging | $2,519.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,535.26 | 2020-2025 | Da Vinci Surgical System |
| Boston Scientific Corporation | $1,417.06 | 2019-2023 | Resolution 360 Clip |
| Medical Device Business Services, INC. | $1,284.14 | 2024 | Monarch |
| Medtronic, INC. | $381.24 | 2022-2023 | Endoflip |
| Atricure, INC. | $328.06 | 2022-2024 | |
| Zimmer Biomet Holdings, INC. | $193.39 | 2024 | Advantagerib |
| Enterra Medical, INC. | $184.76 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $149.45 | 2023-2025 | Calquence |
| Ethicon INC. | $83.20 | 2024-2025 | Monarch Platform |
| Erbe USA INC | $38.15 | 2021-2024 | Vio 3 |
| Pinnacle Biologics, INC | $24.14 | 2022 | |
| Edwards Lifesciences Corporation | $20.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.